On ECHEMI
Home > Drugs > Hunan Wzt Pharmaceutical Co., Ltd.
Hunan Wzt Pharmaceutical Co., Ltd.
  • Founded in:

    2000-02-29
  • Country:

    China China
  • Address:

    No. 219, Biquantan Road, Tianyi Economic Development Zone, Xiangtan, Hunan Province
  • Tax NO.:

    91430300740629832Q
  • Registered Funds:

    8.08 million yuan
  • Website:

  • Email:

Related Drugs
Strong iodine solution
The main ingredient of this product is iodine.
Name Description Content CAS NO. Registered Holders
iodine

Disinfectant and antiseptic. It has bactericidal, antipruritic and astringent effects. It can oxidize the active groups of the cytoplasmic proteins of pathogens and bind to the proteins to denature them. It has an inactivating effect on various types of hepatitis viruses and has a rapid killing effect on Staphylococcus aureus, Escherichia coli, Bacillus cerevisiae, Pseudomonas aeruginosa, Bacillus proteus and Bacillus anthracis. During the medication process, iodine is slowly released in the surfactant, and its bactericidal effect can be long-lasting.

More

Disinfectant and antiseptic. It has bactericidal, antipruritic and astringent effects. It can oxidize the active groups of the cytoplasmic proteins of pathogens and bind to the proteins to denature them. It has an inactivating effect on various types of hepatitis viruses and has a rapid killing effect on Staphylococcus aureus, Escherichia coli, Bacillus cerevisiae, Pseudomonas aeruginosa, Bacillus proteus and Bacillus anthracis. During the medication process, iodine is slowly released in the surfactant, and its bactericidal effect can be long-lasting.

12190-71-5 3
Propyl Gallate for Injection
The main ingredient of this product is propyl gallate
Name Description Content CAS NO. Registered Holders
Propyl gallate

1. It can obviously inhibit the synthesis of thromboxane A2 (TXA2), counteract the platelet aggregation caused by arachidonic acid (AA), and has a stronger and faster antiplatelet aggregation effect than aspirin (ASP). 2. It can enhance the fibrinolytic activity and promote the dissolution of thrombus. 3. It can reduce the specific viscosity of whole blood and plasma, and accelerate the electrophoresis of red blood cells. 4. It can relax the vascular smooth muscle, dilate the artery, and increase the blood flow of the coronary artery and cerebral artery. 5. It can improve the ability to resist hypoxia. 6. It can strongly scavenge free radicals. 7. It can inhibit the inflammatory exudation of capillaries.

More

1. It can obviously inhibit the synthesis of thromboxane A2 (TXA2), counteract the platelet aggregation caused by arachidonic acid (AA), and has a stronger and faster antiplatelet aggregation effect than aspirin (ASP). 2. It can enhance the fibrinolytic activity and promote the dissolution of thrombus. 3. It can reduce the specific viscosity of whole blood and plasma, and accelerate the electrophoresis of red blood cells. 4. It can relax the vascular smooth muscle, dilate the artery, and increase the blood flow of the coronary artery and cerebral artery. 5. It can improve the ability to resist hypoxia. 6. It can strongly scavenge free radicals. 7. It can inhibit the inflammatory exudation of capillaries.

121-79-9 10
Troxerutin for injection
Troxerutin
Name Description Content CAS NO. Registered Holders
Troxerutin

This product can inhibit platelet aggregation and prevent thrombosis. It can also counteract vascular damage caused by 5-hydroxytryptamine and bradykinin, increase capillary resistance, reduce capillary permeability, and prevent edema caused by increased vascular permeability.

More

This product can inhibit platelet aggregation and prevent thrombosis. It can also counteract vascular damage caused by 5-hydroxytryptamine and bradykinin, increase capillary resistance, reduce capillary permeability, and prevent edema caused by increased vascular permeability.

7085-55-4 25
Sisomicin Sulfate Injection
Sisomicin sulfate.
Name Description Content CAS NO. Registered Holders
Sisomycin Sulfate

No specific description provided

More

No specific description provided

53179-09-2 3
Sisomicin Sulfate Injection
Sisomicin sulfate.
Name Description Content CAS NO. Registered Holders
Sisomycin Sulfate

53179-09-2 3
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.